[go: up one dir, main page]

SI1274407T1 - Uses of ppar-gamma agonists in neutrophil-induced diseases - Google Patents

Uses of ppar-gamma agonists in neutrophil-induced diseases

Info

Publication number
SI1274407T1
SI1274407T1 SI200030840T SI200030840T SI1274407T1 SI 1274407 T1 SI1274407 T1 SI 1274407T1 SI 200030840 T SI200030840 T SI 200030840T SI 200030840 T SI200030840 T SI 200030840T SI 1274407 T1 SI1274407 T1 SI 1274407T1
Authority
SI
Slovenia
Prior art keywords
ppar
neutrophil
gamma agonists
induced diseases
diseases
Prior art date
Application number
SI200030840T
Other languages
Slovenian (sl)
Inventor
Colin Houston Macphee
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9908647.2A external-priority patent/GB9908647D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SI1274407T1 publication Critical patent/SI1274407T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
SI200030840T 1999-04-15 2000-04-17 Uses of ppar-gamma agonists in neutrophil-induced diseases SI1274407T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9908647.2A GB9908647D0 (en) 1999-04-15 1999-04-15 Novel compounds
PCT/GB2000/001499 WO2000062766A2 (en) 1999-04-15 2000-04-17 Uses of ppar-gamma agonists in neutrophil-induced diseases
EP00927425A EP1274407B1 (en) 1999-04-15 2000-04-17 Uses of ppar-gamma agonists in neutrophil-induced diseases

Publications (1)

Publication Number Publication Date
SI1274407T1 true SI1274407T1 (en) 2006-06-30

Family

ID=35079603

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200030840T SI1274407T1 (en) 1999-04-15 2000-04-17 Uses of ppar-gamma agonists in neutrophil-induced diseases

Country Status (1)

Country Link
SI (1) SI1274407T1 (en)

Similar Documents

Publication Publication Date Title
PL364720A1 (en) Uses of ppar-gamma agonists in neutrophil-induced diseases
HRP20060251B1 (en) Substituted oxasolidinones and their use
IL190220A0 (en) Novel composition and use
TW450031U (en) Trousers of convenience
IL149374A0 (en) New use and novel n-azabicyclo-amide derivatives
EP1218411A4 (en) Secreted proteins and uses thereof
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
HUP0203721A3 (en) Novel hormonal composition and the use thereof
EG22491A (en) Rest-breaking composition and use thereof
EP1218407A4 (en) Uses of kappa-conotoxin pviia
EP1189938A4 (en) Secreted proteins and uses thereof
SI1274407T1 (en) Uses of ppar-gamma agonists in neutrophil-induced diseases
GB9916474D0 (en) An improved artificial nail and attahment process
EP1179000A4 (en) Secreted proteins and uses thereof
PL350963A1 (en) Use of arylalkanoylpyridazines
IL147103A0 (en) Substituted isoquinoline derivatives and their use as anticonvulsants
HK1055288A1 (en) Novel aqueous composition and use of the same
GB9911606D0 (en) Composition and use
GB9929581D0 (en) Comjpositions and their use
IL137685A0 (en) Processes and intermediates useful to make antifolates
EP1159413A4 (en) Secreted proteins and uses thereof
EG24062A (en) Novel composition and use
IL145152A0 (en) Novel protein and its use
HUP0105189A3 (en) Organoprotective solutions and their use
EP1227149A4 (en) Novel protein and use thereof